{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:15:21Z","timestamp":1776147321491,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2002,7,11]],"date-time":"2002-07-11T00:00:00Z","timestamp":1026345600000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1034\/j.1600-0714.2002.00085.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T07:46:20Z","timestamp":1047455180000},"page":"339-344","source":"Crossref","is-referenced-by-count":25,"title":["High-dose intravenous \u2018pulse\u2019 methylprednisolone in the treatment of severe oropharyngeal pemphigus: a pilot study"],"prefix":"10.1111","volume":"31","author":[{"given":"Michele Davide","family":"Mignogna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Lo Muzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"Ruoppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Lo Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,7,11]]},"reference":[{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB1|cit2","first-page":"186","article-title":"Therapy of pemphigus","volume":"7","author":"Brystryn","year":"1988","journal-title":"Semin Dermatol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB2|cit3","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/archderm.1996.03890360021005","article-title":"Treatment of pemphigus vulgaris with brief high-dose intravenous glucocorticoids","volume":"132","author":"Werth","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB3|cit4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archneur.58.1.91","article-title":"High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes","volume":"58","author":"Leussink","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB4|cit5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.5694\/j.1326-5377.2000.tb124107.x","article-title":"Neurology. Part 4. Multiple sclerosis","volume":"172","author":"Pender","year":"2000","journal-title":"Med J Aust"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB5|cit6","first-page":"47","article-title":"Combination of immunoadsorption therapy and high-dose methylprednisolone in patients with lupus nephritis; possible indications in patients with early stage","volume":"49","author":"Funauchi","year":"1997","journal-title":"J Clin Laboratory Immunol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB6|cit7","first-page":"188","article-title":"High-dose methylprednisolone for autoimmune thrombocytopenia in sarcoidosis","volume":"14","author":"Chakrabarti","year":"1997","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB7|cit8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.410420307","article-title":"Immune deviation following pulse cyclophosphamide\/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia","volume":"42","author":"Smith","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB8|cit9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1212\/WNL.48.3.732","article-title":"Treatment of putative immune-mediated and idiopathic cervical dystonia with intravenous methylprednisolone","volume":"48","author":"Kumar","year":"1997","journal-title":"Neurology"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB9|cit10","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/archderm.1996.03890360091015","article-title":"Pulse glucocorticoid therapy: the \u2018big shot\u2019 revisited","volume":"132","author":"Roujeau","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB10|cit11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1034\/j.1600-0714.2000.290401.x","article-title":"Oral pemphigus: Long-term behaviour and clinical response to treatment with deflazacort in sixteen cases","volume":"29","author":"Mignogna","year":"2000","journal-title":"J Oral Pathol Med"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB11|cit12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1046\/j.1365-4362.2000.00051-5.x","article-title":"Pemphigus induction by influenza vaccination","volume":"39","author":"Mignogna","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB12|cit13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0733-8635(05)70192-3","article-title":"Pulse glucocorticoids","volume":"18","author":"Sabir","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB13|cit14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0030-4220(92)90215-C","article-title":"Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy","volume":"74","author":"Lamey","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB14|cit15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The adjuvant therapy of pemphigus; an update","volume":"132","author":"Brystryn","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB15|cit16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.14219\/jada.archive.1984.0349","article-title":"Adverse side effects associated with prednisone in the treatment of patients with oral inflammatory ulcerative diseases","volume":"109","author":"Lozada","year":"1984","journal-title":"J Am Dent Assoc"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB16|cit17","first-page":"86","volume-title":"Systemic Drugs for Skin Diseases","author":"Wolverton","year":"1991"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB17|cit18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1001\/archderm.1971.04000190016003","article-title":"Pemphigus: 20 years survey of 70 cases","volume":"104","author":"Ryan","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB18|cit19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-4362.1995.tb04430.x","article-title":"Dexamethasone-cyclophosphamide pulse therapy for pemphigus","volume":"34","author":"Paricha","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB19|cit20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB20|cit21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/00016350152509256","article-title":"Immunodiagnosis of pemphigus and mucous membrane pemphigoid","volume":"59","author":"Challacombe","year":"2001","journal-title":"Acta Odontol Scand"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB21|cit22","first-page":"242","article-title":"Comparison of three pulse methylprednisolone regimens in the treatment of rheumatoid arthritis","volume":"15","author":"Radia","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB22|cit23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/03009749209099236","article-title":"Intravenous pulse steroids in rheumatoid arthritis: a comparative dose study","volume":"21","author":"Iglehart","year":"1992","journal-title":"Scand J Rheumatol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB23|cit24","first-page":"125","volume-title":"Systemic Drugs for Skin Diseases","author":"Rapini","year":"1991"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB24|cit25","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0190-9622(84)80193-0","article-title":"Cyclophosphamide","volume":"11","author":"Ahmed","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB25|cit26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0030-4220(82)90212-2","article-title":"Pemphigus vulgaris: a study of six cases treated with levamisole and prednisone","volume":"54","author":"Lozada","year":"1982","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB26|cit27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0030-4220(81)90258-9","article-title":"Prednisone and azathioprine in treatment of patients with vesiculoerosive oral diseases","volume":"52","author":"Lozada","year":"1981","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1034\/j.1600-0714.2002.00085.x-BIB27|cit28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1079-2104(97)90030-5","article-title":"Oral pemphigus vulgaris: a review of the literature and a report of the management of 12 cases","volume":"83","author":"Robinson","year":"1997","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"}],"container-title":["Journal of Oral Pathology & Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0714.2002.00085.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0714.2002.00085.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1034\/j.1600-0714.2002.00085.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T15:19:06Z","timestamp":1600183146000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1034\/j.1600-0714.2002.00085.x"}},"subtitle":["High-dose intravenous \u2018pulse\u2019 methylprednisolone in the treatment of severe oropharyngeal pemphigus"],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,7]]}},"URL":"https:\/\/doi.org\/10.1034\/j.1600-0714.2002.00085.x","archive":["Portico"],"relation":{},"ISSN":["0904-2512"],"issn-type":[{"value":"0904-2512","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}